• Business Partners
• Applera Corporation
• Corporate Structure
• Our History
• Management Team
  • Kathy Ordoñez
  • Samuel Broder
  • Joel Jung
  • Victor K. Lee
  • Steven M. Ruben
  • Susan Schneider
  • Stacey Sias
  • John Sninsky
  • Tom White
  • Mike Zoccoli
• Targeted Medicine

Vice President, Protein Therapeutics

Steven M. Ruben., Ph.D., joined Celera in April 2003. In this new position, Dr. Ruben leads programs to discover and validate novel targets for therapeutics antibody intervention. He oversees the established cell biology, protein chemistry, and mass spectrometry efforts ongoing at Celera’s Rockville campus.

Dr. Ruben has over 15 years of experience leading research in molecular biology and protein chemistry. He brings to Celera extensive experience in target identification and validation, preclinical and clinical development, sample acquisition and protein therapeutics. Dr. Ruben has authored many scientific papers, and he is identified as a co-inventor on over fifty issued US patents. In his most recent position, Dr. Ruben was Vice President, Research for Human Genome Sciences, where he was employed for the past 10 years. In this role, he led a team that was responsible for identification of therapeutic candidates and targets through DNA sequencing, expression profiling, bioinformatics and high throughput screening efforts. He participated in the creation of Human Genome Sciences’ antibody program and was integrally involved in several therapeutic collaborations. Under this leadership, numerous compounds advanced through advanced preclinical evalutations, including two protein therapeutic candidates that are currently in human clinical studies.

Dr. Ruben earned both a Ph.D. and a M.S. in Cell/Molecular Biology from the University of Cincinnati. He also received earned a B.S. in Biochemistry from Ohio State.

Return to Management Team